S. Levine, M. Cohen, N. Blanchard, F. Frederico, M. Magelli et al., Draft guidelines for preventing medication errors in pediatrics, J Pediatr Pharmacol Ther, vol.6, pp.427-470, 2001.

J. Fontan, F. Mille, and F. Brion, L'administration des m?dicaments ? l'enfant hospitalis?, Archives de P?diatrie, vol.11, issue.10, pp.1173-84, 2004.
DOI : 10.1016/j.arcped.2004.06.024

S. Conroy, I. Choonara, P. Impicciatore, A. Mohn, H. Arnell et al., Survey of unlicensed and off label drug use in paediatric wards in European countries, BMJ, vol.320, issue.7227, pp.79-82, 2000.
DOI : 10.1136/bmj.320.7227.79

D. Combeau, J. Fontan, and F. Brion, Analyse du livret thérapeutique d'un hôpital pédiatrique, J Pharm Clin, vol.18, issue.1, pp.5-10, 1999.

P. Joret-descout, S. Prot-labarthe, F. Brion, J. Bataille, J. Hartmann et al., Off-label and unlicensed utilisation of medicines in a French paediatric hospital, International Journal of Clinical Pharmacy, vol.28, issue.100, pp.1222-1229, 2015.
DOI : 10.1592/phco.28.12.1443

Z. Kmietowicz, Drug industry is unwilling to run trials in children, BMJ, vol.320, issue.7246, p.1362, 2000.

J. Corny, D. Lebel, B. Bailey, and J. Bussières, Unlicensed and off-label drug use in children before and after pediatric governmental initiatives, J Pediatr Pharmacol Ther, vol.20, issue.4, pp.316-344, 2015.

J. Mason, M. Pirmohamed, and T. Nunn, Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature, European Journal of Clinical Pharmacology, vol.58, issue.1, pp.21-29, 2012.
DOI : 10.1007/s00228-002-0554-2

S. Conroy, Extemporaneous (magistral) preparation of oral medicines for children in European hospitals, Acta Paediatrica, vol.3, issue.4, pp.408-410, 2003.
DOI : 10.1111/j.1651-2227.2003.tb00568.x

J. Fontan, D. Combeau, and F. Brion, Les pr??parations p??diatriques dans les h??pitaux fran??ais, Archives de P??diatrie, vol.7, issue.8, pp.825-857, 2000.
DOI : 10.1016/S0929-693X(00)80191-8

E. Research and D. Support, Inventory of Paediatric Therapeutic Needs : Nephro-urology, 2013.

A. Paris, Disponible sur, pp.47-57, 2008.

A. Nunn, A. Aindow, and D. Woods, International initiatives on extemporaneous dispensing, International Journal of Pharmaceutics, vol.435, issue.2, pp.135-142, 2012.
DOI : 10.1016/j.ijpharm.2012.05.055

S. Salunke, J. Hempenstall, R. Kendall, B. Roger, C. Mroz et al., European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary?Formulating better medicines for children, International Journal of Pharmaceutics, vol.419, issue.1-2, pp.235-244, 2011.
DOI : 10.1016/j.ijpharm.2011.06.040

T. Sam, T. Ernest, J. Walsh, and J. Williams, A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms ??? An application for paediatric dosage form selection, International Journal of Pharmaceutics, vol.435, issue.2, pp.115-138, 2012.
DOI : 10.1016/j.ijpharm.2012.05.024

M. Bay, C. Saint-laurent, and A. Dupuis, Les pr?parations buvables en p?diatrie, Actualit?s Pharmaceutiques Hospitali?res, vol.7, issue.26, pp.20-24, 2011.
DOI : 10.1016/S1769-7344(11)70353-5

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

A. Cram, J. Breitkreutz, S. Dessetbrethes, T. Nunn, and C. Tuleu, Challenges of developing palatable oral paediatric formulations, International Journal of Pharmaceutics, vol.365, issue.1-2, pp.1-3, 2009.
DOI : 10.1016/j.ijpharm.2008.09.015

V. Ivanovska, C. Rademaker, L. Van-dijk, and A. Mantel-teeuwisse, Pediatric Drug Formulations: A Review of Challenges and Progress, PEDIATRICS, vol.134, issue.2, pp.361-72, 2014.
DOI : 10.1542/peds.2013-3225

N. Shehab, C. Lewis, D. Streetman, and S. Donn, Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates, Pediatric Critical Care Medicine, vol.10, issue.2, pp.256-265, 2009.
DOI : 10.1097/PCC.0b013e31819a383c

A. Kulo, A. Smits, G. Naulaers, D. Hoon, J. Allegaert et al., Biochemical tolerance during low dose propylene glycol exposure in neonates: A formulation-controlled evaluation, DARU Journal of Pharmaceutical Sciences, vol.20, issue.1, p.1, 2012.
DOI : 10.1007/s10337-011-1923-8

S. Conroy, D. Sweis, C. Planner, V. Yeung, J. Collier et al., Interventions to Reduce Dosing Errors in Children, Drug Safety, vol.40, issue.10, pp.1111-1136, 2007.
DOI : 10.2165/00002018-200730120-00004

R. Kaushal, D. Goldmann, C. Keohane, M. Christino, M. Honour et al., Adverse Drug Events in Pediatric Outpatients, Ambulatory Pediatrics, vol.7, issue.5, pp.383-392, 2007.
DOI : 10.1016/j.ambp.2007.05.005

R. Strickley, Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004.
DOI : 10.1023/B:PHAM.0000016235.32639.23

K. Connors, G. Amidon, and V. Stella, Chemical stability of pharmaceuticals: a handbook for pharmacists, 1986.

M. Jackson and A. Lowey, Handbook of extemporaneous preparation: a guide to pharmaceutical compounding, 2010.

I. Costello, Paediatric drug handling, 2007.

S. Stansfield, The art, science, and technology of pharmaceutical compounding, Can J Hosp Pharm, vol.53, issue.4, 2000.

V. Mugoyela and K. Mwambete, Microbial contamination of nonsterile pharmaceuticals in public hospital settings, Therapeutics and Clinical Risk Management, vol.443, 2010.
DOI : 10.2147/TCRM.S12253

A. Salgado, M. Rosa, M. Duarte, and A. Almeida, Stability of spironolactone in an extemporaneously prepared aqueous suspension: the importance of microbiological quality of compounded paediatric formulations, Eur J Hosp Pharm Sci, vol.11, issue.3, pp.68-73, 2005.

T. Ernest, D. Elder, L. Martini, M. Roberts, and J. Ford, Developing paediatric medicines: identifying the needs and recognizing the challenges, Journal of Pharmacy and Pharmacology, vol.26, issue.6403, pp.1043-55, 2007.
DOI : 10.2165/00002018-200326080-00001

A. Haywood and B. Glass, Liquid Dosage Forms Extemporaneously Prepared from Commercially Available Products ? Considering New Evidence on Stability, Journal of Pharmacy & Pharmaceutical Sciences, vol.16, issue.3, pp.441-55, 2013.
DOI : 10.18433/J38887

URL : http://doi.org/10.18433/j38887

T. Johnson, Modelling approaches to dose estimation in children, British Journal of Clinical Pharmacology, vol.55, issue.6, pp.663-672, 2005.
DOI : 10.1046/j.1365-2125.2003.01881.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884869

M. Christensen, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: Time for Permanent Status, The Journal of Pediatric Pharmacology and Therapeutics, vol.17, issue.2, pp.140-141, 2012.
DOI : 10.5863/1551-6776-17.2.140

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470432

E. Dempsey and K. Connolly, Who are the PDCO?, European Journal of Pediatrics, vol.161, issue.2, pp.233-238, 2014.
DOI : 10.1016/j.jpeds.2012.02.029

J. Flynn, The changing face of pediatric hypertension in the era of the childhood obesity epidemic, Pediatric Nephrology, vol.357, issue.Suppl 1, pp.1059-66, 2013.
DOI : 10.1056/NEJMsa073166

J. Lo, A. Sinaiko, M. Chandra, M. Daley, L. Greenspan et al., Prehypertension and Hypertension in Community-Based Pediatric Practice, PEDIATRICS, vol.131, issue.2, pp.415-424, 2013.
DOI : 10.1542/peds.2012-1292

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557407

K. Redwine, A. Acosta, T. Poffenbarger, R. Portman, and J. Samuels, Development of Hypertension in Adolescents with Pre-Hypertension, The Journal of Pediatrics, vol.160, issue.1
DOI : 10.1016/j.jpeds.2011.07.010

E. Lurbe, R. Cifkova, J. Cruickshank, M. Dillon, I. Ferreira et al., Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension, Journal of Hypertension, vol.27, issue.9, pp.1719-1761, 2009.
DOI : 10.1097/HJH.0b013e32832f4f6b

J. André, J. Deschamps, and R. Gueguen, La tension artérielle chez l'enfant et l'adolescent. Valeurs rapportées à l'âge et à la taille chez 17 067 sujets, Arch Fr Pédiatrie, vol.37, issue.7, pp.477-82, 1980.

J. André, Hypertension artérielle chez l'enfant et l'adolescent. EMC -Cardiol- Angéiologie, pp.478-90, 2005.

J. Flynn, Hypertension in the neonatal period, Current Opinion in Pediatrics, vol.24, issue.2, pp.197-204, 2012.
DOI : 10.1097/MOP.0b013e32834f8329

A. Greenough, E. Emery, and H. Gamsu, Dexamethasone and hypertension in preterm infants, European Journal of Pediatrics, vol.112, issue.2, pp.134-139, 1992.
DOI : 10.1007/BF01958959

C. Williams, L. Hayman, S. Daniels, T. Robinson, J. Steinberger et al., Cardiovascular Health in Childhood: A Statement for Health Professionals From the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association, Circulation, vol.106, issue.1, pp.143-60, 2002.
DOI : 10.1161/01.CIR.0000019555.61092.9E

M. Nahata, Lack of pediatric drug formulations, Pediatrics, vol.104, pp.607-616, 1999.

E. Yoon, K. Dombkowski, A. Rocchini, J. Lin, and M. Davis, Off-Label Utilization of Antihypertensive Medications in Children, Ambulatory Pediatrics, vol.7, issue.4, pp.299-303, 2007.
DOI : 10.1016/j.ambp.2007.04.005

J. Misurac, K. Nichols, and A. Wilson, Pharmacologic Management of Pediatric Hypertension, Pediatric Drugs, vol.117, issue.4, pp.31-43, 2016.
DOI : 10.1016/S0022-3476(05)80711-5

S. Chaturvedi, D. Lipszyc, C. Licht, J. Craig, and R. Parekh, Pharmacological interventions for hypertension in children, Cochrane Database Syst Rev, issue.2, p.8117, 2014.

J. Ingelfinger, The Child or Adolescent with Elevated Blood Pressure, New England Journal of Medicine, vol.370, issue.24, p.1075, 2014.
DOI : 10.1056/NEJMcp1001120

R. Woroniecki and J. Flynn, How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists, Pediatric Nephrology, vol.288, issue.6, pp.791-798, 2005.
DOI : 10.1097/00126097-200306000-00001

G. Simonetti, M. Rizzi, R. Donadini, and M. Bianchetti, Effects of antihypertensive drugs on blood pressure and proteinuria in childhood, Journal of Hypertension, vol.25, issue.12, pp.2370-2376, 2007.
DOI : 10.1097/HJH.0b013e3282efeb7e

J. Flynn and D. Pasko, Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension, Pediatric Nephrology, vol.15, issue.3, pp.302-318, 2000.
DOI : 10.1007/s004670000480

P. Bruyne and J. Walle, Management of hypertension in children and adolescents, Acta Clinica Belgica, vol.361, issue.17, pp.87-94, 2015.
DOI : 10.1517/14740338.1.1.39

P. Chu, M. Campbell, S. Miller, and K. Hill, Anti-hypertensive drugs in children and adolescents, World J Cardiol, vol.6, issue.5, pp.234-278, 2014.

D. Silverstein, J. Palmer, H. Baluarte, C. Brass, S. Conley et al., Use of calcium-channel blockers in pediatric renal transplant recipients, Pediatric Transplantation, vol.21, issue.4, pp.288-92, 1999.
DOI : 10.1016/S0031-3955(16)36251-4

M. Temple and M. Nahata, Treatment of Pediatric Hypertension, Pharmacotherapy, vol.35, issue.2, pp.140-50, 2000.
DOI : 10.1002/j.1552-4604.1995.tb04116.x

R. Portman, K. Mcniece, R. Swinford, M. Braun, and J. Samuels, Pediatric Hypertension: Diagnosis, Evaluation, Management, and Treatment for the Primary Care Physician, Current Problems in Pediatric and Adolescent Health Care, vol.35, issue.7, pp.262-94, 2005.
DOI : 10.1016/j.cppeds.2005.06.001

J. Flynn, Efficacy and safety of prolonged amlodipine treatment in hypertensive children, Pediatric Nephrology, vol.183, issue.5, pp.631-636, 2005.
DOI : 10.1007/s00467-004-1781-9

T. Webb, I. Shatat, and Y. Miyashita, Therapy of Acute Hypertension in Hospitalized Children and Adolescents, Current Hypertension Reports, vol.65, issue.5, p.425, 2014.
DOI : 10.1097/OGX.0b013e3181e2c795

V. Yiu, E. Orrbine, R. Rosychuk, P. Maclaine, P. Goodyer et al., The safety and use of short-acting nifedipine in hospitalized hypertensive children, Pediatric Nephrology, vol.19, issue.6, pp.644-50, 2004.
DOI : 10.1007/s00467-004-1444-x

H. Trachtman, R. Frank, J. Mahan, R. Portman, I. Restaino et al., Clinical trial of extended-release felodipine in pediatric essential hypertension, Pediatr Nephrol Berl Ger, vol.18, issue.6, pp.548-53, 2003.

R. Meyers and A. Siu, Pharmacotherapy Review of Chronic Pediatric Hypertension, Clinical Therapeutics, vol.33, issue.10, pp.1331-56, 2011.
DOI : 10.1016/j.clinthera.2011.09.003

J. Flynn, T. Mottes, P. Brophy, D. Kershaw, W. Smoyer et al., Intravenous nicardipine for treatment of severe hypertension in children, The Journal of Pediatrics, vol.139, issue.1, pp.38-43, 2001.
DOI : 10.1067/mpd.2001.114030

J. Treluyer, P. Hubert, P. Jouvet, S. Couderc, and M. Cloup, Intravenous nicardipine in hypertensive children, European Journal of Pediatrics, vol.85, issue.9, pp.712-716, 1993.
DOI : 10.1111/j.1365-2125.1989.tb05439.x

S. Kirkiacharian, Guide de chimie médicinale et médicaments. Tec & Doc Lavoisier, 2010.

A. Baranda, R. Alonso, R. Jiménez, and W. Weinmann, Instability of calcium channel antagonists during sample preparation for LC?MS?MS analysis of serum samples, Forensic Science International, vol.156, issue.1, pp.23-34, 2006.
DOI : 10.1016/j.forsciint.2004.11.014

M. Maurin, S. Rowe, C. Koval, and M. Hussain, Solubilization of Nicardipine Hydrochloride via Complexation and Salt Formation, Journal of Pharmaceutical Sciences, vol.83, issue.10, pp.1418-1438, 1994.
DOI : 10.1002/jps.2600831011

G. Amidon, H. Lennernäs, V. Shah, and J. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-433, 1995.
DOI : 10.1023/A:1016212804288

R. Munoz, E. Cruz, . Da, C. Vetterly, D. Cooper et al., Handbook of pediatric cardiovascular drugs, 2014.

M. Hubert and J. Lusson, Pharmacokinetics of oral nicardipine in children with cardiovascular diseases, cystic fibrosis and systemic arterial hypertension In : Pharmacocinétique : de la recherche à la clinique, pp.513-514, 1992.

S. Decramer and J. Gouyon, Inhibiteurs calciques dans l'hypertension artérielle de l'enfant. Médecine Thérapeutique, pp.309-325, 2002.

V. Eymery, O. Niel, A. Mousnier, and E. Bérard, Posologies des principaux m?dicaments dans le traitement de l?hypertension art?rielle de l?enfant en France, Archives de P?diatrie, vol.16, issue.10, pp.1419-1442, 2009.
DOI : 10.1016/j.arcped.2009.06.010

C. Buttet, P. Cochat, D. Floret, J. Malfroy, and L. David, Traitement des poussées hypertensives de l'enfant par la nicardipine, Pédiatrie, vol.43, issue.5, pp.447-50, 1988.

E. Tack and J. Perlman, Renal failure in sick hypertensive premature infants receiving captopril therapy, The Journal of Pediatrics, vol.112, issue.5, pp.805-815, 1988.
DOI : 10.1016/S0022-3476(88)83213-X

J. Dasta, B. Boucher, G. Brophy, H. Cohen, E. Hassan et al., Intravenous to Oral Conversion of Antihypertensives: A Toolkit for Guideline Development, Annals of Pharmacotherapy, vol.54, issue.9, pp.1430-1477, 2010.
DOI : 10.2307/30146964

S. Chen, M. Hsieh, S. Chao, E. Chang, P. Wang et al., Separation and structure determination of nicardipine photoproducts by LC-ESI-MS, Biomedical Chromatography, vol.286, issue.1-2, pp.1008-1020, 2008.
DOI : 10.1562/0031-8655(2004)080<0565:PSOTIO>2.0.CO;2

G. Ragno and C. Vetuschi, UV derivative spectrophotometric assay of nicardipine and its photodegradation product, Pharmazie, vol.53, issue.9, pp.628-659, 1998.

S. Al-ghannam and A. Olayan, Stability-indicating HPLC method for the determination of nicardipine in capsules and spiked human plasma. Identification of degradation products using HPLC/MS, Arabian Journal of Chemistry, 2014.
DOI : 10.1016/j.arabjc.2014.11.044

M. Bonferoni, G. Mellerio, P. Giunchedi, C. Caramella, and U. Conte, Photostability evaluation of nicardipine ? HCl solutions, International Journal of Pharmaceutics, vol.80, issue.1-3, pp.109-126, 1992.
DOI : 10.1016/0378-5173(92)90268-7

J. Squella, Y. Borges, C. Celedon, P. Peredo, and L. Nuñez-vergara, Nicardipine: Differential pulse polarography and photodecomposition, Electroanalysis, vol.8, issue.3, pp.221-226, 1991.
DOI : 10.1080/00032718808059910

N. Gibbs, N. Traynor, B. Johnson, and J. Ferguson, In vitro phototoxicity of nifedipine: Sequential induction of toxic and non-toxic photoproducts with UVA radiation, Journal of Photochemistry and Photobiology B: Biology, vol.13, issue.3-4, pp.275-88, 1992.
DOI : 10.1016/1011-1344(92)85067-5

T. Gadkari, P. Chandrachood, R. Torane, S. Tele, N. Deshpande et al., Forced degradation study to develop and validate stability indicating RP-LC method for quantification of nicardipine HCl in bulk and tablet formulation, Int J Pharm Pharm Sci, vol.2, pp.162-166

M. Ubale, V. Dhakane, and V. Chaudhari, A validated stability-indicating HPLC assay method for Nicardipine Hydrochloride in bulk drug and dosage form, Elixir Int J, issue.41, pp.5867-70, 2011.

H. Lotfy, M. Hegazy, M. Fattah, and L. , Stability indicating spectrophotometric methods determination of nicardipine in the presence of its alkaline induced degradation products, Int J Pharm Pharm Sci, vol.8, issue.3, pp.62-68, 2016.

H. Aliabadi, M. Romanick, V. Somayaji, P. Mahdipoor, and A. Lavasanifar, Stability of compounded thioguanine oral suspensions, American Journal of Health-System Pharmacy, vol.68, issue.10, pp.900-908, 2011.
DOI : 10.2146/ajhp100163

J. Morrison, R. Lugo, J. Thigpen, and S. Brown, Stability of Extemporaneously Prepared Lansoprazole Suspension at Two Temperatures, The Journal of Pediatric Pharmacology and Therapeutics, vol.18, issue.2, pp.122-129, 2013.
DOI : 10.5863/1551-6776-18.2.122

F. Navid, R. Christensen, P. Minkin, C. Stewart, W. Furman et al., Stability of Sunitinib in Oral Suspension, Annals of Pharmacotherapy, vol.4, issue.7-8, pp.962-968, 2008.
DOI : 10.2165/00128072-200204060-00004

J. Pitt, Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry, Clin Biochem Rev, vol.30, issue.1, pp.19-34, 2009.

M. Narayanam, T. Handa, P. Sharma, S. Jhajra, P. Muthe et al., Critical practical aspects in the application of liquid chromatography?mass spectrometric studies for the characterization of impurities and degradation products, Journal of Pharmaceutical and Biomedical Analysis, vol.87, pp.191-217, 2014.
DOI : 10.1016/j.jpba.2013.04.027

N. Vu, J. Lou, and T. Kupiec, Quality control analytical methods: microbial limit tests for nonsterile pharmaceuticals, Part 1, Int J Pharm Compd, vol.18, issue.3, pp.213-234, 2014.

P. Hubert, J. Nguyen-huu, and B. Boulanger, Validation des procédures analytiques quantitatives : harmonisation des démarches, STP Pharma Prat, vol.13, issue.3, pp.101-139, 2003.

E. Topic and Q. Specifications, Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances

E. Commission, Eudralex volume 3 -Medicinal products for human and veterinary use: Guidelines 3AQ11A: Specifications and control tests on the finished product, 1992.

I. Harmonised and T. Guideline, validation of analytical procedures: definitions and terminology (Q2A, Tripartite International Conference on Harmonization (ICH) text, ICH Tech coordination, 1994.

I. Guidance, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 2015.

A. Nationale and D. Pharmacie, Dictionnaire des sciences pharmaceutiques & biologiques. 2e éd. Paris: Editions Louis Pariente, 2001.

A. Polo, M. Poy, S. Bautista, M. Arenas, F. Salinas et al., Osmolalidad de las formas farmac?uticas orales l?quidas en un hospital para su aplicaci?n en neonatos, Farmacia Hospitalaria, vol.31, issue.5, p.311, 2007.
DOI : 10.1016/S1130-6343(07)75395-3

R. Rowe, Handbook of pharmaceutical excipients, 2009.

K. Alexander and N. Thyagarajapuram, Formulation and accelerated stability studies for an extemporaneous suspension of amiodarone hydrochloride, Int J Pharm Compd, vol.7, issue.5, pp.389-93, 2003.

J. Fawcett, D. Boulton, R. Jiang, and D. Woods, Stability of hydrocortisone oral suspensions prepared from tablets and powder, Ann Pharmacother, vol.29, issue.10, pp.987-90, 1995.

A. Santovena, M. Llabre-'s, and J. Farina, Quality control and physical and chemical stability of hydrocortisone oral suspension: an interlaboratory study, Int J Pharm Compd, vol.14, issue.5, pp.430-435, 2010.

S. Zietsman, G. Kilian, M. Worthington, and C. Stubbs, Formulation Development and Stability Studies of Aqueous Metronidazole Benzoate Suspensions Containing Various Suspending Agents, Drug Development and Industrial Pharmacy, vol.52, issue.2, pp.191-198, 2007.
DOI : 10.1016/0378-5173(83)90144-8

M. Turner, J. Duncan, U. Shah, T. Metsvaht, H. Varendi et al., European Study of Neonatal Exposure to Excipients: An update, International Journal of Pharmaceutics, vol.457, issue.1, pp.357-365, 2013.
DOI : 10.1016/j.ijpharm.2013.08.078

S. Alade, R. Brown, and A. Paquet, Polysorbate 80 and E-Ferol toxicity, Pediatrics, vol.77, issue.4, pp.593-600, 1986.

M. Casas, J. Álvarez, and M. Lucero, Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients, Pharmaceutical Development and Technology, vol.15, issue.3, pp.271-279, 2015.
DOI : 10.1016/S0731-7085(02)00325-4

C. Dreno, T. Gicquel, M. Harry, O. Tribut, F. Aubin et al., Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution, Annales Pharmaceutiques Fran?aises, vol.73, issue.1, pp.31-37, 2015.
DOI : 10.1016/j.pharma.2014.06.006

A. Garg, S. Garg, and R. She, Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation, Burns, vol.37, issue.7, pp.1150-1153, 2011.
DOI : 10.1016/j.burns.2011.06.007

P. Kintzel, T. Zhao, B. Wen, and D. Sun, Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection, American Journal of Health-System Pharmacy, vol.71, issue.23, pp.2061-2066, 2014.
DOI : 10.2146/ajhp130697

S. Hendrickx, A. Verón, A. Van-schepdael, and E. Adams, Applicability of refractometry for fast routine checking of hospital preparations, European Journal of Pharmaceutical Sciences, vol.86, pp.13-22, 2016.
DOI : 10.1016/j.ejps.2016.02.014

C. Bardin, A. Astier, A. Vulto, G. Sewell, J. Vigneron et al., Guidelines for the practical stability studies of anticancer drugs: A European consensus conference, Annales Pharmaceutiques Fran?aises, vol.69, issue.4, pp.221-252, 2011.
DOI : 10.1016/j.pharma.2011.07.002

A. Van-der-vossen, I. Van-der-velde, O. Smeets, D. Postma, A. Vermes et al., Design and stability study of an oral solution of amlodipine besylate for pediatric patients, European Journal of Pharmaceutical Sciences, vol.92, pp.220-223, 2016.
DOI : 10.1016/j.ejps.2016.05.019

M. Nahata, R. Morosco, and E. Willhite, Stability of Nifedipine in Two Oral Suspensions Stored at Two Temperatures, Journal of the American Pharmaceutical Association (1996), vol.42, issue.6, pp.865-872, 2002.
DOI : 10.1331/108658002762063709